• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Hemoadsorption with CytoSorb.

作者信息

Poli Elettra C, Rimmelé Thomas, Schneider Antoine G

机构信息

Service de Médecine Intensive Adulte, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.

Service d'anesthésie-réanimation, Hôpital Edouard Herriot, Lyon, France.

出版信息

Intensive Care Med. 2019 Feb;45(2):236-239. doi: 10.1007/s00134-018-5464-6. Epub 2018 Nov 16.

DOI:10.1007/s00134-018-5464-6
PMID:30446798
Abstract
摘要

相似文献

1
Hemoadsorption with CytoSorb.使用CytoSorb进行血液吸附
Intensive Care Med. 2019 Feb;45(2):236-239. doi: 10.1007/s00134-018-5464-6. Epub 2018 Nov 16.
2
Hemoadsorption by CytoSorb in septic patients: a case series.细胞吸附剂（CytoSorb）对脓毒症患者的血液吸附：病例系列
Crit Care. 2017 Mar 27;21(1):74. doi: 10.1186/s13054-017-1662-9.
3
Cytokine clearance with CytoSorb® during cardiac surgery: a pilot randomized controlled trial.细胞因子清除术联合 CytoSorb® 在心脏手术中的应用：一项前瞻性随机对照试验。
Crit Care. 2019 Apr 3;23(1):108. doi: 10.1186/s13054-019-2399-4.
4
Opportunities, controversies, and challenges of extracorporeal hemoadsorption with CytoSorb during ECMO.体外膜肺氧合（ECMO）期间使用CytoSorb进行体外血液吸附的机遇、争议与挑战。
Artif Organs. 2021 Oct;45(10):1240-1249. doi: 10.1111/aor.14025. Epub 2021 Aug 8.
5
[Acute blood purification using extracorporeal ultrafiltration method (ECUM) for treatment of heart failure].[采用体外超滤法（ECUM）进行急性血液净化治疗心力衰竭]
Nihon Rinsho. 2007 May 28;65 Suppl 5:251-4.
6
Extracorporeal auxiliary xenoperfusion: animal model of support in fulminant liver failure.体外辅助异种灌注：暴发性肝衰竭支持治疗的动物模型
Transplant Proc. 1996 Apr;28(2):749-50.
7
Clinical Utility of Extracorporeal Cytokine Hemoadsorption Therapy: A Literature Review.体外细胞因子血液吸附治疗的临床实用性：文献综述。
Blood Purif. 2018;46(4):337-349. doi: 10.1159/000492379. Epub 2018 Sep 3.
8
Pediatric sepsis: challenges and adjunctive therapies.小儿脓毒症：挑战与辅助治疗。
Crit Care Clin. 2013 Apr;29(2):203-22. doi: 10.1016/j.ccc.2012.11.003. Epub 2013 Jan 3.
9
CytoSorb, a novel therapeutic approach for patients with septic shock: a case report.细胞吸附疗法——脓毒性休克患者的一种新型治疗方法：一例病例报告
Int J Artif Organs. 2015 Aug;38(8):461-4. doi: 10.5301/ijao.5000429. Epub 2015 Aug 31.
10
First successful combination of ECMO with cytokine removal therapy in cardiogenic septic shock: a case report.体外膜肺氧合（ECMO）与细胞因子清除疗法在心源性脓毒性休克中的首次成功联合应用：一例病例报告
Int J Artif Organs. 2015 Feb;38(2):113-6. doi: 10.5301/ijao.5000382. Epub 2015 Feb 3.

引用本文的文献

1
Challenges in the use of the CytoSorb adsorber in an intensive care patient with liver dysfunction of unknown origin: a case report.在一名病因不明的肝功能不全重症监护患者中使用CytoSorb吸附器的挑战：病例报告
J Med Case Rep. 2025 Sep 8;19(1):440. doi: 10.1186/s13256-025-05503-9.
2
From critical care to organ preservation: the potential role of hemadsorption in transplantation-a narrative review.从重症监护到器官保存：血液吸附在移植中的潜在作用——一篇叙述性综述
Hepatobiliary Surg Nutr. 2025 Aug 1;14(4):608-629. doi: 10.21037/hbsn-24-446. Epub 2025 Apr 15.
3
Artificial liver support with Cytosorb and continuous veno-venous hemodiafiltration versus advanced organ support (ADVOS) for critically ill patients with hyperbilirubinemia and acute-on-chronic liver failure (ACLF).

本文引用的文献

1
Removal of Bilirubin with a New Adsorbent System: In Vitro Kinetics.新型吸附剂系统清除胆红素：体外动力学。
Blood Purif. 2019;47(1-3):10-15. doi: 10.1159/000492378. Epub 2018 Sep 14.
2
In vitro comparison of the adsorption of inflammatory mediators by blood purification devices.血液净化装置对炎症介质吸附作用的体外比较
Intensive Care Med Exp. 2018 May 4;6(1):12. doi: 10.1186/s40635-018-0177-2.
3
Impact of intraoperative cytokine adsorption on outcome of patients undergoing orthotopic heart transplantation-an observational study.
采用Cytosorb和持续静脉-静脉血液透析滤过的人工肝支持与用于高胆红素血症和慢加急性肝衰竭（ACLF）重症患者的高级器官支持（ADVOS）的对比研究
BMC Nephrol. 2025 Aug 4;26(1):432. doi: 10.1186/s12882-025-04342-6.
4
Pilot study: In vitro reduction of hemoglobin from canine blood with hemoperfusion using the Cytosorb® adsorber.初步研究：使用Cytosorb®吸附器通过血液灌流对犬类血液中的血红蛋白进行体外还原。
PLoS One. 2025 Jul 28;20(7):e0328306. doi: 10.1371/journal.pone.0328306. eCollection 2025.
5
Immunomodulation in Pediatric Sepsis: A Narrative Review.儿童脓毒症中的免疫调节：一篇叙述性综述
J Clin Med. 2025 Apr 25;14(9):2983. doi: 10.3390/jcm14092983.
6
Regulated cell death and DAMPs as biomarkers and therapeutic targets in normothermic perfusion of transplant organs. Part 2: implementation strategies.作为移植器官常温灌注生物标志物和治疗靶点的程序性细胞死亡和损伤相关分子模式。第2部分：实施策略。
Front Transplant. 2025 Apr 24;4:1575703. doi: 10.3389/frtra.2025.1575703. eCollection 2025.
7
CytoSorb Hemadsorption in Cardiogenic Shock: A Real-World Analysis of Hemodynamics, Organ Function, and Clinical Outcomes During Mechanical Circulatory Support.细胞吸附柱血液吸附在心源性休克中的应用：机械循环支持期间血流动力学、器官功能及临床结局的真实世界分析
Biomedicines. 2025 Jan 30;13(2):324. doi: 10.3390/biomedicines13020324.
8
To Hemoadsorb or Not to Hemoadsorb-Do We Have the Answer Yet? An Updated Meta-Analysis on the Use of CytoSorb in Sepsis and Septic Shock.进行血液吸附还是不进行血液吸附——我们有答案了吗？关于在脓毒症和感染性休克中使用CytoSorb的最新荟萃分析。
Biomedicines. 2025 Jan 13;13(1):180. doi: 10.3390/biomedicines13010180.
9
Kidney REPLACEment therapies in patients with acute kidney injury and RHABDOmyolysis (ReplaceRhabdo): a pilot trial.急性肾损伤合并横纹肌溶解患者的肾脏替代治疗（ReplaceRhabdo）：一项试点试验。
BMC Nephrol. 2025 Jan 14;26(1):23. doi: 10.1186/s12882-025-03945-3.
10
Hemadsorption with CytoSorb®: focus on the latest experiences in cardiac surgery patients.使用CytoSorb®进行血细胞吸附：关注心脏手术患者的最新经验。
J Artif Organs. 2024 Dec 21. doi: 10.1007/s10047-024-01485-5.
术中细胞因子吸附对原位心脏移植患者结局的影响：一项观察性研究。
Clin Transplant. 2018 Apr;32(4):e13211. doi: 10.1111/ctr.13211. Epub 2018 Feb 27.
4
Broad adsorption of sepsis-related PAMP and DAMP molecules, mycotoxins, and cytokines from whole blood using CytoSorb® sorbent porous polymer beads.使用CytoSorb®吸附剂多孔聚合物微球从全血中广泛吸附脓毒症相关的病原体相关分子模式（PAMP）和损伤相关分子模式（DAMP）分子、霉菌毒素及细胞因子。
PLoS One. 2018 Jan 25;13(1):e0191676. doi: 10.1371/journal.pone.0191676. eCollection 2018.
5
The effect of a novel extracorporeal cytokine hemoadsorption device on IL-6 elimination in septic patients: A randomized controlled trial.一种新型体外细胞因子血液吸附装置对脓毒症患者白细胞介素-6清除的影响：一项随机对照试验。
PLoS One. 2017 Oct 30;12(10):e0187015. doi: 10.1371/journal.pone.0187015. eCollection 2017.
6
International registry on the use of the CytoSorb® adsorber in ICU patients : Study protocol and preliminary results.关于CytoSorb®吸附器在重症监护病房患者中应用的国际注册研究：研究方案及初步结果。
Med Klin Intensivmed Notfmed. 2019 Nov;114(8):699-707. doi: 10.1007/s00063-017-0342-5. Epub 2017 Sep 4.
7
Extracorporeal cytokine elimination as rescue therapy in refractory septic shock: a prospective single-center study.体外细胞因子清除作为难治性感染性休克的挽救治疗：一项前瞻性单中心研究
J Artif Organs. 2017 Sep;20(3):252-259. doi: 10.1007/s10047-017-0967-4. Epub 2017 Jun 6.
8
Hemoadsorption treatment of patients with acute infective endocarditis during surgery with cardiopulmonary bypass - a case series.体外循环心脏手术期间急性感染性心内膜炎患者的血液吸附治疗——病例系列
Int J Artif Organs. 2017 May 29;40(5):240-249. doi: 10.5301/ijao.5000583. Epub 2017 May 19.
9
Hemoadsorption by CytoSorb in septic patients: a case series.细胞吸附剂（CytoSorb）对脓毒症患者的血液吸附：病例系列
Crit Care. 2017 Mar 27;21(1):74. doi: 10.1186/s13054-017-1662-9.
10
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016.拯救脓毒症运动：脓毒症和脓毒性休克管理国际指南：2016 年版。
Intensive Care Med. 2017 Mar;43(3):304-377. doi: 10.1007/s00134-017-4683-6. Epub 2017 Jan 18.